These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 22056400)

  • 1. THE EFFECT OF EXENATIDE THERAPY IN PREVIOUSLY INSULIN-TREATED TYPE 2 DIABETIC PATIENTS.
    Yaşar HY; Ceyhan BO; Pamuk BO; Demirpence M; Ertugrul O; Ertugrul D
    Acta Endocrinol (Buchar); 2017; 13(4):447-453. PubMed ID: 31149215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exenatide promotes regeneration of injured rat sciatic nerve.
    Kuyucu E; Gümüs B; Erbas O; Oltulu F; Bora A
    Neural Regen Res; 2017 Apr; 12(4):637-643. PubMed ID: 28553346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exenatide's effect in reducing weight and glycosylated hemoglobin level in an Arab population with type 2 diabetes.
    Bashier AM; Abdelgadir EI; Khalifa AA; Rashid F; Abuelkeir SM; Bachet FE
    Saudi Med J; 2014 Nov; 35(11):1404-7. PubMed ID: 25399222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exenatide added to insulin therapy: a retrospective review of clinical practice over two years in an academic endocrinology outpatient setting.
    Yoon NM; Cavaghan MK; Brunelle RL; Roach P
    Clin Ther; 2009 Jul; 31(7):1511-23. PubMed ID: 19695400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial.
    Heine RJ; Van Gaal LF; Johns D; Mihm MJ; Widel MH; Brodows RG;
    Ann Intern Med; 2005 Oct; 143(8):559-69. PubMed ID: 16230722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of adding exenatide to a thiazolidinedione in suboptimally controlled type 2 diabetes: a randomized trial.
    Zinman B; Hoogwerf BJ; Durán García S; Milton DR; Giaconia JM; Kim DD; Trautmann ME; Brodows RG
    Ann Intern Med; 2007 Apr; 146(7):477-85. PubMed ID: 17404349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of exenatide therapy over 82 weeks on glycaemic control and weight in over-weight metformin-treated patients with type 2 diabetes mellitus.
    Ratner RE; Maggs D; Nielsen LL; Stonehouse AH; Poon T; Zhang B; Bicsak TA; Brodows RG; Kim DD
    Diabetes Obes Metab; 2006 Jul; 8(4):419-28. PubMed ID: 16776749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors associated with primary failure to exenatide and non goal attainment in patients with type 2 diabetes.
    Preumont V; Hermans MP; Bergman M; Buysschaert M
    Acta Clin Belg; 2012; 67(6):411-5. PubMed ID: 23340146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of exenatide in poorly controlled type 2 diabetes.
    Kaimal N; Schofield J; Zaki A; Patel R; Sharma M; McCourt E; Imtiaz KE
    QJM; 2012 Apr; 105(4):321-6. PubMed ID: 22056400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incretin mimetics and dipeptidyl peptidase 4 inhibitors in clinical trials for the treatment of type 2 diabetes.
    Mikhail N
    Expert Opin Investig Drugs; 2008 Jun; 17(6):845-53. PubMed ID: 18491986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation.
    Waugh N; Cummins E; Royle P; Clar C; Marien M; Richter B; Philip S
    Health Technol Assess; 2010 Jul; 14(36):1-248. PubMed ID: 20646668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Exenatide--an alternative to insulin in the treatment of type 2 diabetes?].
    Kjeldsen R; Sandbaek A
    Ugeskr Laeger; 2008 Sep; 170(39):3039-43. PubMed ID: 18822227
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.